PD-L1 expression in metastatic neuroblastoma as an additional mechanism for limiting immune surveillance

Abstract

T cells have a higher expression of activation markers. Overall, our data show that a PD-L1-mediated immune resistance mechanism occurs in metastatic neuroblasts and provide a biological rationale for blocking the PD-1/PD-Ls axis in future combined immunotherapeutic approaches.